ncRNA name
hsa-miR-130b
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
PTEN
Cancer name
Renal Cell Carcinoma
Cancer site
Kindey
Treatment type
Chemotherapy
Drug
Sunitinib
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
32
Male patients
25
Female patients
7
Age range and number
Not available
PMID
Description
Knockdown of miR-130b improved sunitinib resistance in Caki-1-SR cells.
Tissue resource
renal cell carcinoma tissue samples
Experiment
qRT-PCR,Western blot
Institute
Hiroshima University
Country
Japan
Continent
Asia